The United States Gastrointestinal (GI) Stents Market represents the largest share within North America, supported by a high burden of gastrointestinal diseases, increasing cancer prevalence, and strong adoption of advanced medical technologies. Healthcare providers are increasingly utilizing GI stents as a minimally invasive alternative to surgery for managing malignant and benign...